Sinopharm Needs Trial Results to Decide if COVID-19 Vaccine Needs Booster Shot: Executive

BEIJING (Reuters) – China National Pharmaceutical Group (Sinopharm) will need to assess results from overseas Phase III clinical trials to

Read more

Canada to Require New Assessment of AstraZeneca Vaccine Benefits, Risks Based on Age

OTTAWA/TORONTO (Reuters) – Canada will modify its approval of AstraZeneca’s COVID-19 vaccine to require a new analysis of its benefits

Read more

J&J Developing Several Next-Generation COVID-19 Vaccines, Says CEO

(Reuters) – Johnson & Johnson is developing several next-generation COVID-19 vaccines against the emerging variants of the coronavirus, Chief Executive

Read more

States Prep for COVID-19 Vaccines for All Adults in May if Promised Supplies Arrive

(Reuters) – State public health departments are ready to begin giving COVID-19 shots to all adult residents if the White

Read more